Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

 

agreements shall be extended to provide for an exercise period of up to 180 days following the termination without Cause; provided, however, that such post-termination exercise grace period shall not be extended beyond the period of time that would enable the stock option to remain exempt under IRS Regulation 409A.

 

This Amendment sets forth the entire amendment and modification to the Agreement intended by the parties. Further, this Amendment and the Agreement constitute the entire agreement and understanding of the parties relating to the subject matter contained therein. The amendments and modifications to the Agreement are specifically limited to the terms and conditions discussed herein. The remainder of the terms and conditions of the Agreement, as agreed to by the parties, remains in full force and effect.

 

THIS AMENDMENT IS EXECUTED by the parties as of the date first written above.

 

Proteon Therapeutics, Inc. (“Company”):

 

 

 

 

 

/s/ Timothy P. Noyes

 

Timothy P. Noyes

 

President & CEO

 

 

 

 

Date:

6-22-09

 

 

 

 

 

 

 

Steven K. Burke

 

 

 

 

 

/s/ Steven K. Burke

 

Steven K. Burke

 

SVP and CMO

 

 

 

 

Date:

6-26-09